Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95 | -62 | -33 | -150 | -100 |
| Other Working Capital | -22 | -34 | -21 | 3 | -20 |
| Other Operating Activity | 4 | 4 | 4 | 0 | 0 |
| Operating Cash Flow | $-113 | $-92 | $-49 | $-147 | $-120 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 61 | 61 | 61 | 38 | 28 |
| Investing Cash Flow | $61 | $61 | $61 | $39 | $28 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 808 | 808 | 808 | 916 | 916 |
| End Cash Position | 756 | 777 | 819 | 808 | 824 |
| Net Cash Flow | $-52 | $-31 | $12 | $-108 | $-92 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113 | -92 | -49 | -147 | -120 |
| Free Cash Flow | -113 | -92 | -49 | -147 | -120 |